Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07787182 A Study of LY4405094 in Healthy Participants and Participants With Alzh… |
LY4405094 | Alzheimer | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Eli Lilly and Company | United States · Accel Research Sites - NeuroStudies C… | 2026-09 → 2028-01 | Ouvrir |
| NCT06585787 A Study to Evaluate KarXT as a Treatment for Psychosis Associated With … |
KarXT | Alzheimer | Phase 3 | RECRUITING | En attente / non publié | Karuna Therapeutics, Inc., a Bris… | United States, Argentina, Belgium, Brazil, Bulgaria, … | 2024-09-26 → 2026-12-22 | Ouvrir |
| NCT06767124 Veech Ketone Ester to Support Brain Energy in Mild Cognitive Impairment… |
Veech Ketone Ester to Support Bra… | Alzheimer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | University of Pennsylvania | Canada · Lawson Research Institute, London, Canada | 2026-09-01 → 2028-05 | Ouvrir |
| NCT00449865 NET-PD LS-1 Creatine in Parkinson's Disease |
Creatine | Parkinson | Phase 3 | TERMINATED | En attente / non publié | University of Rochester | United States, Canada · Barrow Neurological Clinics A… | 2007-03 → 2014-05 | Ouvrir |
| NCT03633513 Parkinson's Disease Inflammatory Biomarker Profiling |
Parkinson's Disease Inflammatory … | Parkinson | À vérifier | TERMINATED | En attente / non publié | Longevity Biotech | United States · Corporal Michael J. Crescenz VA Medic… | 2018-07-10 → 2020-03-13 | Ouvrir |
| NCT00873392 NICOPARK2 — Efficacy of Transdermal Nicotine, on Motor Symptoms in Adva… |
Transdermal nicotine | Parkinson | Phase 2 | COMPLETED | En attente / non publié | Assistance Publique - Hôpitaux de… | France · Groupe Hospitalier Albert Chenevier Henri Mo… | 2009-02 → 2013-05 | Ouvrir |
| NCT06816810 A Study to Evaluate Efficacy, Safety and Tolerability of Hydroxychloroq… |
Hydroxychloroquine (HCQ) | Parkinson | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Ottawa Hospital Research Institute | Canada · The Ottawa Hospital, Ottawa, Canada | 2025-03 → 2027-03 | Ouvrir |
| NCT00024622 PET Scanning in Parkinson s Disease |
18F-Fluoro-L-dopa | Parkinson | À vérifier | COMPLETED | En attente / non publié | National Institute of Mental Heal… | United States · National Institutes of Health Clinica… | 2002-03-15 | Ouvrir |
| NCT01621581 AAV2-GDNF for Advanced Parkinson s Disease |
Convection enhanced delivery/AAV2… | Parkinson | Phase 1 | COMPLETED | En attente / non publié | National Institute of Neurologica… | United States · National Institutes of Health Clinica… | 2013-03-13 → 2022-02-04 | Ouvrir |
| NCT04664634 A Digital Therapeutic Platform for Swallowing and Drooling Problems in … |
Aria Sensor | Parkinson | Phase 3 | RECRUITING | En attente / non publié | Northwestern University | United States · Northwestern University, Evanston, Un… | 2025-04-01 → 2026-10-31 | Ouvrir |
| NCT07705373 MyMusiQ — A Novel Digital Music-based Autonomous Personalized Walking I… |
MR-005 (MedRhythms, Inc., Portlan… | Parkinson | Non applicable | RECRUITING | En attente / non publié | Boston University Charles River C… | United States · Boston University Center for Neuroreh… | 2026-08-20 → 2029-02-28 | Ouvrir |
| NCT06996652 PRISMS — An Exploratory Study of the Potential for Rational Immune Syst… |
Adalimumab | Parkinson | Phase 2 | RECRUITING | En attente / non publié | Yale University | United States, Canada · Beth Israel Deaconess Medical… | 2026-08-17 → 2030-01-01 | Ouvrir |
| NCT00943748 FAIR-PARK-I — Efficacy and Safety of the Iron Chelator Deferiprone in P… |
deferiprone | Parkinson | Phase 2/3 | COMPLETED | En attente / non publié | University Hospital, Lille | France · Service de Neurologie, Clinique Neurologique… | 2009-10 → 2011-10 | Ouvrir |
| NCT04165070 KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (… |
Pembrolizumab | Parkinson | Phase 1/2 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Hungary, Israel, Italy, Poland, South … | 2019-12-19 → 2032-10-13 | Ouvrir |
| NCT06592014 Lithium for Parkinson's: an Extension Trial |
Lithium for Parkinson's: an Exten… | Parkinson | Phase 1/2 | ENROLLING_BY_INVITATION | En attente / non publié | State University of New York at B… | United States · UBMD Neurology, Williamsville, United… | 2024-08-09 → 2026-11-01 | Ouvrir |
| NCT07780461 PDSPPB — Characterization and Validation of the Short Physical Performa… |
PDSPPB — Characterization and Val… | Parkinson | À vérifier | RECRUITING | En attente / non publié | University of Vigo | Spain · Asociación de Parkinson de la Provincia de Po… | 2026-08-01 → 2026-12-25 | Ouvrir |
| NCT05319730 A Study to Evaluate Investigational Agents With or Without Pembrolizuma… |
paclitaxel | Parkinson | Phase 1/2 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States, Brazil, Chile, China, Germany, Italy, … | 2023-05-16 → 2029-04-10 | Ouvrir |
| NCT04165798 KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents W… |
Tumor Tissue Collection | Parkinson | À vérifier | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Hungary, Israel, Italy, Poland, South … | 2019-12-19 → 2032-02-13 | Ouvrir |
| NCT06807385 The Effect of the Reaction Training in Parkinson's Disease |
The Effect of the Reaction Traini… | Parkinson | Non applicable | COMPLETED | En attente / non publié | Gazi University | Turkey (Türkiye) · Gazi University, Ankara, Turkey (T… | 2025-02-17 → 2025-11-06 | Ouvrir |
| NCT06780085 A Study of Investigational Agents in Participants With Previously Treat… |
Raludotatug Deruxtecan | Parkinson | Phase 2 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Chile, Germany, Greece, Hungary, Israe… | 2025-05-13 → 2032-03-12 | Ouvrir |
| NCT07428447 Syn-T — Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identif… |
Syn-T — Analysis of Cutaneous Pho… | Parkinson | À vérifier | RECRUITING | En attente / non publié | CND Life Sciences | United States · CND Clinical Research Center, Scottsd… | 2026-02-18 → 2029-02 | Ouvrir |
| NCT05128175 Comparative Bioavailability Study of Carbidopa/Levodopa Extended-Releas… |
WD-1603 Carbidopa-Levodopa Extend… | Parkinson | Phase 1 | COMPLETED | En attente / non publié | Shanghai WD Pharmaceutical Co., L… | India · Lambda Therapeutic Research Ltd., Ahmedabad, … | 2021-10-29 → 2021-12-09 | Ouvrir |
| NCT07662837 Effects of Tai Chi Therapy Versus Qi-Gong in Stage-I Parkinson's Patien… |
Effects of Tai Chi Therapy Versus… | Parkinson | Non applicable | RECRUITING | En attente / non publié | Lahore University of Biological a… | Pakistan · Ghurki Trust and Teaching Hospital, Lahore… | 2026-05-30 → 2026-10-10 | Ouvrir |
| NCT03615326 Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epide… |
Pembrolizumab | Parkinson | Phase 3 | COMPLETED | En attente / non publié | Merck Sharp & Dohme LLC | United States, Australia, Brazil, Chile, China, Franc… | 2018-10-05 → 2025-11-12 | Ouvrir |
| NCT03553485 Effects of VNS on RT-induced Inflammation and Prognosis of Patients Wit… |
transcutaneous vagus nerve stimul… | SEP | Non applicable | UNKNOWN | En attente / non publié | Kyoungwon Baik | Belgium · UZ Brussels, Brussels, Belgium | 2018-08-08 → 2019-12 | Ouvrir |